Elantas Beck India Regulatory Approval

Financial Results

Elantas Beck India Q2 FY27 Results: Net Profit ₹45.5 Cr, Up 25.3% YoY

Elantas Beck India Ltd reported revenue from operations of ₹265.3 Cr (+22.5% YoY) and net profit of ₹45.5 Cr (+25.3% YoY) for Q2 FY27.

Key figure

Net profit ₹45.5 Cr · +25.3% YoY

Management Change

Elantas Beck India Management Change

Mr. Sanjay Kulkarni has resigned from his position as Chief Financial Officer and Key Managerial Personnel of ELANTAS Beck India Ltd, effective October 21, 2026.

Other Announcement

Elantas Beck India Other Announcement

The company has filed its quarterly shareholding pattern as per SEBI Regulation 31(1)(b) for the quarter ended September 30, 2026.

Board Meeting Date

Elantas Beck India Board Meeting Date

ELANTAS Beck India schedules its Board meeting for 28 October 2026 to approve Q1 and nine-month results. Trading window remains closed until 48 hours post-declaration.

Financial ResultsAlfa AlertAn Alfa Alert is ALFA Finder's top-priority alert: filings that can move a stock, such as orders, fund raises and approvals, sent to subscribers on Telegram within seconds of reaching the exchange.

Elantas Beck India Q1 FY27 Results: Net Profit ₹70.9 Cr, Up 80.4% YoY

Elantas Beck India Ltd reported revenue from operations of ₹283.4 Cr (+35.0% YoY) and net profit of ₹70.9 Cr (+80.4% YoY) for Q1 FY27.

Key figure

Net profit ₹70.9 Cr · +80.4% YoY

Board Meeting Date

Elantas Beck India Board Meeting Date

Elantas Beck India Ltd scheduled a Board Meeting for August 4, 2026. The board will consider and approve unaudited financial results for the period ended June 30, 2026.

Regulatory ApprovalShalby Ltd SHALBYAlfa AlertAn Alfa Alert is ALFA Finder's top-priority alert: filings that can move a stock, such as orders, fund raises and approvals, sent to subscribers on Telegram within seconds of reaching the exchange.

Shalby Regulatory Approval

Shalby Hospital, Jabalpur received CMHO permission to resume normal operations, including patient admissions, on its previously affected floor. The hospital has now fully resumed healthcare services.

Regulatory ApprovalKalyani Cast-Tech Ltd 544023Alfa AlertAn Alfa Alert is ALFA Finder's top-priority alert: filings that can move a stock, such as orders, fund raises and approvals, sent to subscribers on Telegram within seconds of reaching the exchange.

Kalyani Cast-Tech Regulatory Approval

Kalyani Cast-Tech received RDSO Stage-I concept design approval for its new container-carrying wagon under PWDA. Stage-II detailed design approval is still required, subject to dynamics simulation conditions.

Regulatory ApprovalMukka Proteins Ltd MUKKAAlfa AlertAn Alfa Alert is ALFA Finder's top-priority alert: filings that can move a stock, such as orders, fund raises and approvals, sent to subscribers on Telegram within seconds of reaching the exchange.

Mukka Proteins Regulatory Approval

Mukka Proteins received a US FDA facility registration certificate, valid October 1, 2026 to December 31, 2027. The company says the registration supports its engagement with US customers and markets.

Execution

October 1, 2026 to December 31, 2027

Regulatory ApprovalCanara Bank CANBKAlfa AlertAn Alfa Alert is ALFA Finder's top-priority alert: filings that can move a stock, such as orders, fund raises and approvals, sent to subscribers on Telegram within seconds of reaching the exchange.

Canara Bank Regulatory Approval

Canara Bank received RBI permission to exercise the call option on its Basel III AT1 bonds (ISIN INE476A08134) of Rs.1,500 Crore. The bank is now in process of exercising the call as per the issue terms.

Value

₹1,500 Cr

Regulatory ApprovalAlembic Pharmaceuticals Ltd APLLTDAlfa AlertAn Alfa Alert is ALFA Finder's top-priority alert: filings that can move a stock, such as orders, fund raises and approvals, sent to subscribers on Telegram within seconds of reaching the exchange.

Alembic Pharmaceuticals Regulatory Approval

Alembic Pharmaceuticals received USFDA final approval for Valganciclovir for Oral Solution, 50 mg/mL. This adds to its cumulative 247 USFDA ANDA approvals.

Regulatory ApprovalKFIN Technologies Ltd KFINTECHAlfa AlertAn Alfa Alert is ALFA Finder's top-priority alert: filings that can move a stock, such as orders, fund raises and approvals, sent to subscribers on Telegram within seconds of reaching the exchange.

KFIN Technologies Regulatory Approval

KFin Technologies' Thai subsidiary received a Foreign Business License from Thailand's Ministry of Commerce. The license enables the subsidiary to conduct permitted business activities under local law.